Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 23;25:100417. doi: 10.1016/j.phro.2023.100417

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Fig. 1 — T₂ weighted images with the corresponding tumour blood flow (BF) maps as an overlay. Patient 1 had a tumour BF at baseline (a) of 93 ml/min/100 g, and a decrease (-ΔBF) of 31 % after therapy (b). The patient had a 25 % reduction in tumour volume during treatment. The patient was alive without local recurrence or metastasis after 38 months. Patient 2 had a tumour BF at baseline (c) of 111 ml/min/100 g, and an increase of 30 % after therapy (d). The patient had a 70 % reduction in tumour volume during treatment. The patient had a local recurrence after 10 months and died 2 months thereafter.